What does Maraviroc (Selzentry) do in plain English—and how does it work inside your body?
Maraviroc is an FDA-regulated CCR5 Co-receptor Antagonist (RxNorm RxCUI 728223). Mechanistically, 12.1 Mechanism of Action Maraviroc is an HIV-1 antiviral drug . In clinical regimens (150 mg/1 Tablet, Film Coated, 300 mg/1 Tablet, Film Coated), Maraviroc executes ccr5 co-receptor antagonist target modulation documented under federal RxCUI 728223 and DailyMed 2023-08-18 labeling. [1][2].
When your doctor writes a prescription for Maraviroc (RxNorm RxCUI 728223, also dispensed under brand names including Selzentry), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action Maraviroc is an HIV-1 antiviral drug . In clinical regimens (150 mg/1 Tablet, Film Coated, 300 mg/1 Tablet, Film Coated), Maraviroc executes ccr5 co-receptor antagonist target modulation documented under federal RxCUI 728223 and DailyMed 2023-08-18 labeling. [2].
Across real-world patient logs on dotMD (78% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Maraviroc tablet bottle and confirm with your pharmacist that it matches your prescribed strength (150 mg/1 Tablet, Film Coated, 300 mg/1 Tablet, Film Coated, Kit, 150mg Tablet, 300mg Tablet).